Not logged in.png)
Share.png)
SaveShare Save A randomized, double-blind, placebo-controlled phase III study evaluating the preventive effect of diclofenac cream on capecitabine-related hand-foot syndrome: study protocol of J-SUPPORT2401/JORTC-SUP06 (J-DIRECT)
Iimura, Yohei; Ishiguro, Hiroshi; Hashimoto, Hironobu; Nojima, Masanori; Oyamada, Shunsuke; Mori, Keita; Ariyoshi, Keisuke; Kuroda, Seiichiro; Hirakawa, Satoshi; Fujiwara, Noriko; Yokota, Tomoya; Zenda, Sadamoto; Matsuoka, Hiromichi; Boku, Narikazu Share Save A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010) (vol 24, pg 479, 2020)Takizawa, Kohei; Ono, Hiroyuki; Hasuike, Noriaki; Takashima, Atsuo; Minashi, Keiko; Boku, Narikazu; Kushima, Ryoji; Katayama, Hiroshi; Ogawa, Gakuto; Fukuda, Haruhiko; Fujisaki, Junko; Oda, Ichiro; Yano, Tomonori; Hori, Shinichiro; Doyama, Hisashi; Hirasawa, Kingo; Yamamoto, Yoshinobu; Ishihara, Ryu; Tanabe, Satoshi; Niwa, Yasumasa; Nakagawa, Masahiro; Terashima, Masanori; Muto, Manabu; Gastrointestinal Endoscopy Grp GIESG; SCSG; Japan Clin Oncol Grp Share Save Potential impact of APC mutation on survival via immune evasion through WNT signaling activation in HER2-positive gastric cancer treated with trastuzumab (tmab), nivolumab (nivo), and chemotherapyWakatsuki, T.; Mashima, T.; Yamamoto, N.; Ooki, A.; Shoji, H.; Chin, K.; Ogura, M.; Kiyotani, K.; Nakayama, I.; Osumi, H.; Fukuoka, S.; Shinozaki, E.; Minashi, K.; Hara, H.; Takeuchi, K.; Seimiya, H.; Kitano, S.; Boku, N.; Yamaguchi, K.; Takahari, D. Share Save Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 trialBoku, Narikazu; Omori, Takeshi; Shitara, Kohei; Sakuramoto, Shinichi; Yamaguchi, Kensei; Kato, Ken; Kadowaki, Shigenori; Tsuji, Kunihiro; Ryu, Min-Hee; Oh, Do-Youn; Oh, Sang Cheul; Rha, Sun Young; Lee, Keun-Wook; Chung, Ik-Joo; Sym, Sun Jin; Chen, Li-Tzong; Chen, Jen-Shi; Bai, Li-Yuan; Nakada, Takashi; Hagihara, Shunsuke; Makino, Reina; Nishiyama, Eiji; Kang, Yoon-Koo Share Save Shared decision-making support program for older patients with advanced cancer using a question prompt list and geriatric assessment: A pilot randomized controlled trialObama, Kyoko; Fujimori, Maiko; Boku, Narikazu; Matsuoka, Ayumu; Mori, Keita; Okizaki, Ayumi; Miyaji, Tempei; Okamura, Masako; Majima, Yoshiyuki; Goto, Shinichi; Shimazu, Taichi; Uchitomi, Yosuke Share Save A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018GMatsumoto, Toshihiko; Yamamoto, Yoshiyuki; Kotaka, Masahito; Masuishi, Toshiki; Tsuji, Yasushi; Shoji, Hirokazu; Hirata, Kenro; Tsuduki, Takao; Makiyama, Akitaka; Izawa, Naoki; Takahashi, Naoki; Tsuda, Masahiro; Yasui, Hisateru; Ohta, Takashi; Kito, Yosuke; Otsu, Satoshi; Hironaka, Shuichi; Yamazaki, Kentaro; Boku, Narikazu; Hyodo, Ichinosuke; Yoshimura, Kenichi; Muro, Kei Share Save Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trialKang, Yoon-Koo; Ryu, Min-Hee; Di Bartolomeo, Maria; Chau, Ian; Yoon, Harry; Kim, Jong Gwang; Lee, Keun-Wook; Oh, Sang Chul; Takashima, Atsuo; Kryzhanivska, Anna; Chao, Yee; Evesque, Ludovic; Schenker, Michael; Mcginn, Arlo; Zhao, Yufan; Lee, Jennifer; Wyrwicz, Lucjan; Boku, Narikazu Share Save Early endpoints of a randomized phase II trial of preoperative chemotherapy with S-1/CDDP with or without trastuzumab followed by surgery for HER2-positive resectable gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger Study)Tokunaga, Masanori; Machida, Nozomu; Mizusawa, Junki; Ito, Seiji; Yabusaki, Hiroshi; Hirao, Motohiro; Watanabe, Masaya; Imamura, Hiroshi; Kinoshita, Takahiro; Yasuda, Takushi; Hihara, Jun; Fukuda, Haruhiko; Yoshikawa, Takaki; Boku, Narikazu; Terashima, Masanori Share Save Randomized phase II study comparing neoadjuvant 5-fluorouracil/oxaliplatin/docetaxel versus docetaxel/oxaliplatin/S-1 for patients with type 4 or large type 3 gastric cancerHashimoto, Tadayoshi; Nakayama, Izuma; Ohashi, Manabu; Mizusawa, Junki; Kawachi, Hiroshi; Kita, Ryosuke; Fukuda, Haruhiko; Kurokawa, Yukinori; Boku, Narikazu; Yoshikawa, Takaki; Terashima, Masanori Share Save Randomized controlled phase III trial to investigate superiority of robot-assisted gastrectomy over laparoscopic gastrectomy for clinical stage T1-4aN0-3 gastric cancer patients (JCOG1907, MONA LISA study): a study protocolMakuuchi, Rie; Terashima, Masanori; Terada, Mitsumi; Mizusawa, Junki; Kita, Ryosuke; Tokunaga, Masanori; Omori, Takeshi; Ojima, Toshiyasu; Ehara, Kazuhisa; Watanabe, Masaya; Yanagimoto, Yoshitomo; Nunobe, Souya; Kinoshita, Takahiro; Ito, Seiji; Nishida, Yasunori; Hihara, Jun; Boku, Narikazu; Kurokawa, Yukinori; Yoshikawa, Takaki Share Save Role of tumor markers before or during chemotherapy for poorly differentiated neuroendocrine carcinomas of the digestive system: An exploratory analysis of JCOG1213Satake, T.; Morizane, C.; Machida, N.; Honma, Y.; Okusaka, T.; Boku, N.; Kato, K.; Ogawa, G.; Sano, Y.; Imaoka, H.; Kobayashi, S.; Terashima, T.; Ikeda, M.; Okano, N.; Yamaguchi, K.; Sato, T.; Mizuno, N.; Kitagawa, Y.; Terashima, M.; Ueno, M. Share Save Clinical Impact of ERBB2 copy number and tumor mutation burden (TMB) in patients with HER2-positive advanced gastric cancer treated by nivolumab (N-mab) plus trastuzumab (T-mab) and standard chemotherapyShoji, H.; Wakatsuki, T.; Takahari, D.; Yamamoto, N.; Ooki, A.; Chin, K.; Kurihara, N.; Kiyotani, K.; Mashima, T.; Ogura, M.; Nakayama, I.; Minashi, K.; Hara, H.; Shinozaki, E.; Ishizuka, N.; Kitano, S.; Seimiya, H.; Takeuchi, K.; Boku, N.; Yamaguchi, K. Share Save A phase I study of pevonedistat plus capeOX in patients with advanced gastric cancer refractory to platinum (NCCH-1811)Takahari, D.; Shoji, H.; Ooki, A.; Hirano, H.; Okita, N. T.; Nagashima, K.; Adachi, J.; Yamaguchi, K.; Kato, K.; Boku, N. Share Save APC mutation (mt.), MYC, and GATA6 amplifications (amp.) were associated with worse survival in HER2-positive advanced gastric cancer patients treated with S-1/ capecitabine plus oxaliplatin combined with trastuzumab (Tmab) and nivolumab (N-mab)Wakatsuki, T.; Takahari, D.; Yamamoto, N.; Ooki, A.; Chin, K.; Kurihara, N.; Mashima, T.; Ogura, M.; Nakayama, I.; Fukuoka, S.; Hirano, H.; Minashi, K.; Hara, H.; Kato, K.; Ishizuka, N.; Kitano, S.; Seimiya, H.; Takeuchi, K.; Boku, N.; Yamaguchi, K. Share Save The primary results of an intergroup phase III randomized controlled trial comparing ramucirumab plus irinotecan with irinotecan in the third or later line treatment beyond progression after ramucirumab for advanced gastric cancer (RINDBeRG trial)Kadowaki, S.; Sakai, D.; Kawabata, R.; Hara, H.; Yasui, H.; Takahashi, M.; Hirao, M.; Imai, H.; Minashi, K.; Kawakami, T.; Satake, H.; Matsuyama, J.; Sakamoto, Y.; Sawada, K.; Kataoka, M.; Kawakami, H.; Shimokawa, T.; Boku, N.; Satoh, T. Share Save Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G)Takahashi, Naoki; Hara, Hiroki; Nagashima, Kengo; Hirata, Kenro; Masuishi, Toshiki; Matsumoto, Toshihiko; Kawakami, Hisato; Yamazaki, Kentaro; Hironaka, Shuichi; Boku, Narikazu; Muro, Kei Share Save Share Save A Phase II Trial of Trifluridine/Tipiracil in Combination with Cetuximab Rechallenge in Patients with RAS Wild-Type mCRC Refractory to Prior Anti-EGFR Antibodies: WJOG8916G TrialIzawa, Naoki; Masuishi, Toshiki; Takahashi, Naoki; Shoji, Hirokazu; Yamamoto, Yoshiyuki; Matsumoto, Toshihiko; Sugiyama, Keiji; Kajiwara, Takeshi; Kawakami, Kentaro; Aomatsu, Naoki; Kondoh, Chihiro; Kawakami, Hisato; Takegawa, Naoki; Esaki, Taito; Shimokawa, Mototsugu; Nishio, Kazuto; Narita, Yukiya; Hara, Hiroki; Sunakawa, Yu; Boku, Narikazu; Moriwaki, Toshikazu; Nakajima, Takako Eguchi; Muro, Kei Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
GASTRIC CANCER.png)
